Testing effectiveness (Phase 2)Study completedNCT05253807
What this trial is testing
Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Relapsed or Refractory Advanced Non-Small Cell Lung Cancer With an FGFR Alteration
Who this might be right for
Non-Small Cell Lung Cancer (NSCLC)
Incyte Corporation 8